DiscoverJAMA Author InterviewsEvaluating Treatments for Amyotrophic Lateral Sclerosis
Evaluating Treatments for Amyotrophic Lateral Sclerosis

Evaluating Treatments for Amyotrophic Lateral Sclerosis

Update: 2025-02-17
Share

Description

The HEALEY ALS platform is an innovative first attempt at platform trials in ALS, looking to slow ALS disease progression. Author Sabrina Paganoni, MD, PhD, of Massachusetts General Hospital and Harvard Medical School, discusses results of the first 4 drug regimens from this platform trial and how this study design makes efficient use of resources, with JAMA Deputy Editor Christopher Muth, MD.

Related Content:

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Evaluating Treatments for Amyotrophic Lateral Sclerosis

Evaluating Treatments for Amyotrophic Lateral Sclerosis